Edition:
India

CVS Health Corp (CVS.N)

CVS.N on New York Stock Exchange

57.38USD
16 Jul 2019
Change (% chg)

$-0.06 (-0.10%)
Prev Close
$57.44
Open
$57.37
Day's High
$57.49
Day's Low
$56.88
Volume
1,079,262
Avg. Vol
2,397,314
52-wk High
$82.12
52-wk Low
$51.72

About

CVS Health Corporation, together with its subsidiaries, is an integrated pharmacy healthcare company. The Company provides pharmacy care for the senior community through Omnicare, Inc. (Omnicare) and Omnicare's long-term care (LTC) operations, which include distribution of pharmaceuticals, related pharmacy consulting and other... (more)

Overall

Beta: 0.89
Market Cap(Mil.): $74,619.85
Shares Outstanding(Mil.): 1,299.09
Dividend: 0.50
Yield (%): 3.48

Financials

White House scraps key plan to lower U.S. drug prices; may target drugmakers

NEW YORK/WASHINGTON The Trump administration on Thursday scrapped one of its most ambitious proposals for lowering prescription medicine prices, backing down from a policy aimed at health insurers and raising the possibility of new measures focused on drugmakers.

12 Jul 2019

White House scraps key plan to lower U.S. drug prices; may target drugmakers

NEW YORK/WASHINGTON The Trump administration on Thursday scrapped one of its most ambitious proposals for lowering prescription medicine prices, backing down from a policy aimed at health insurers and raising the possibility of new measures focused on drugmakers.

12 Jul 2019

UPDATE 5-White House scraps key plan to lower U.S. drug prices; may target drugmakers

NEW YORK/WASHINGTON, July 11 The Trump administration on Thursday scrapped one of its most ambitious proposals for lowering prescription medicine prices, backing down from a policy aimed at health insurers and raising the possibility of new measures focused on drugmakers.

12 Jul 2019

REFILE-UPDATE 4-White House scraps key plan to lower U.S. drug prices; may target drugmakers

NEW YORK/WASHINGTON, July 11 The Trump administration on Thursday scrapped one of its most ambitious proposals for lowering prescription medicine prices, backing down from a policy aimed at health insurers and raising the possibility of new measures focused on drugmakers.

12 Jul 2019

UPDATE 2-CVS to expand health hubs to 1,500 stores by end of 2021

NEW YORK, June 4 CVS Health Corp said it would offer expanded health services such as nutrition counseling and blood pressure screenings in 1,500 stores by the end of 2021, following through on plans announced during the pharmacy chain's 2018 acquisition of health insurer Aetna.

04 Jun 2019

CVS to expand health hubs to 1,500 stores by end of 2021

NEW YORK, June 4 CVS Health Corp said it will offer expanded health services such as nutrition counseling and blood pressure screenings in 1,500 stores by the end of 2021, following through on plans announced during the pharmacy chain's 2018 acquisition of health insurer Aetna.

04 Jun 2019

U.S. judge calls hearing on merger of CVS and Aetna: court filing

WASHINGTON A federal judge on Monday ordered up to three days of hearings next month to consider CVS Health Corp's $69 billion merger with Aetna, which has closed but must still get court approval.

14 May 2019

U.S. judge calls hearing on merger of CVS and Aetna -court filing

WASHINGTON, May 13 A federal judge on Monday ordered up to three days of hearings next month to consider CVS Health Corp's $69 billion merger with Aetna, which has closed but must still get court approval.

14 May 2019

McKesson meets full-year profit estimates, renews partnership with CVS

U.S. drug distributor McKesson Corp forecast a full-year profit on Wednesday that matched analysts' estimates, easing some fears over drug pricing pressures and costs of opioid-related litigations.

08 May 2019

UPDATE 2-McKesson meets full-year profit estimates, renews partnership with CVS

May 8 U.S. drug distributor McKesson Corp forecast a full-year profit on Wednesday that matched analysts' estimates, easing some fears over drug pricing pressures and costs of opioid-related litigations.

08 May 2019

Earnings vs. Estimates